New Drug for Recurring Cases of Breast Cancer
498234
(Dec. 8) -- Researchers believe they have a better drug for preventing recurring cases of breast cancer. After breast cancer surgery, women are often given the drug Tamoxifen to keep the cancer from coming back.
14
A new type of drug shows growing promise as a more potent way for many breast cancer patients to significantly cut their risk of a recurrence, researchers reported yesterday.
56445
WEDNESDAY, Jan. 16 (HealthDay News) -- A new genetic test that helps assess the risk of tumor recurrence and long-term survival for patients with relatively high-risk breast cancer has been approved by the U.S. Food and Drug Administration.
31407
A new type of breast cancer drug is  superior to the old standard, tamoxifen, in older women and  should now be the first drug used to treat the cancer, U.S. and  British researchers said on Wednesday.
262303
The results of the five-year trial involving 9,300 women, the largest ever on breast cancer, show that women taking the aromatase inhibitor anastrozole (brand name Arimidex) were less likely to have their cancer spread.
393648
GlaxoSmithKline's new breast cancer pill Tykerb might help prevent the growth of tumors in some people with a hard-to-treat form of the disease, U.S. researchers reported on Sunday.
563877
A new type of breast cancer drug is  clearly superior to the old standard, tamoxifen, in many women  and should now be the first drug used to treat the cancer, U.S.  and British researchers said on Wednesday.
542831
British women who have had breast cancer can now have a new treatment which has been found to prevent the disease returning and to prolong survival.
202457
Older women with breast cancer are being encouraged to use a new drug which is better at preventing re-occurrence of the disease, has fewer side effects - but costs Â£1,000 a year instead of Â£30.
320147
Cancer drug shows exceptional promise as it moves toward FDA review.
95999
A newer drug clearly outperforms tamoxifen at preventing breast cancer from returning and should become the first-choice treatment for most women who have had the disease, doctors are reporting.
134401
A drug currently prescribed to combat advanced breast cancer can now be used to help prevent the disease from recurring in women who have been treated for early forms of the disease, the US Food and Drug Administration ruled Friday.
458471
12/8/04- the drug tamoxifen has long been the 1st line of therapy for preventing the return of breast cancer, but researchers say another drug may be more effective and could soon become the 1st choice treatment for post-menopausal women who&#39;ve had the
156055
TUESDAY, Feb. 13 (HealthDay News) -- Switching to newer breast cancer drugs, called aromatase inhibitors, after two to three years of treatment with tamoxifen may extend disease-free survival and slightly reduce the risk of death in women who've been treated for early stage disease, an international study finds.
329902
A new drug may give older women with early stages of breast cancer a better chance of beating the disease and stopping it returning and spreading.
139693
Postmenopausal women with early breast cancer who take tamoxifen for five years appear to have a 30 percent lower risk of dying from coronary heart disease than
601151
NEW YORK  - Aromatase inhibitors, a class of drugs used to ward off the recurrence of breast cancer after surgery, increase the risk of cardiovascular disorders slightly more than does treatment with tamoxifen, a new study shows.